1. Home
  2. CING vs CMBM Comparison

CING vs CMBM Comparison

Compare CING & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • CMBM
  • Stock Information
  • Founded
  • CING 2012
  • CMBM 2011
  • Country
  • CING United States
  • CMBM United States
  • Employees
  • CING N/A
  • CMBM N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • CING Health Care
  • CMBM Technology
  • Exchange
  • CING Nasdaq
  • CMBM Nasdaq
  • Market Cap
  • CING 17.3M
  • CMBM 14.3M
  • IPO Year
  • CING 2021
  • CMBM 2019
  • Fundamental
  • Price
  • CING $5.50
  • CMBM $0.94
  • Analyst Decision
  • CING Strong Buy
  • CMBM Strong Buy
  • Analyst Count
  • CING 4
  • CMBM 2
  • Target Price
  • CING $30.67
  • CMBM $5.50
  • AVG Volume (30 Days)
  • CING 104.9K
  • CMBM 1.6M
  • Earning Date
  • CING 08-12-2025
  • CMBM 08-07-2025
  • Dividend Yield
  • CING N/A
  • CMBM N/A
  • EPS Growth
  • CING N/A
  • CMBM N/A
  • EPS
  • CING N/A
  • CMBM N/A
  • Revenue
  • CING N/A
  • CMBM $172,215,000.00
  • Revenue This Year
  • CING N/A
  • CMBM N/A
  • Revenue Next Year
  • CING N/A
  • CMBM $17.73
  • P/E Ratio
  • CING N/A
  • CMBM N/A
  • Revenue Growth
  • CING N/A
  • CMBM N/A
  • 52 Week Low
  • CING $1.80
  • CMBM $0.23
  • 52 Week High
  • CING $20.83
  • CMBM $2.18
  • Technical
  • Relative Strength Index (RSI)
  • CING 66.64
  • CMBM 61.88
  • Support Level
  • CING $4.25
  • CMBM $0.65
  • Resistance Level
  • CING $6.01
  • CMBM $1.49
  • Average True Range (ATR)
  • CING 0.34
  • CMBM 0.18
  • MACD
  • CING 0.09
  • CMBM 0.05
  • Stochastic Oscillator
  • CING 71.02
  • CMBM 49.77

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: